Institutes
Refine
Year of publication
- 2020 (245) (remove)
Document Type
- Article (196)
- Preprint (39)
- Doctoral Thesis (10)
Language
- English (245) (remove)
Has Fulltext
- yes (245)
Is part of the Bibliography
- no (245)
Keywords
- COVID-19 (9)
- SARS-CoV-2 (5)
- bladder cancer (4)
- Aortic stenosis (3)
- Hypoxia (3)
- Inflammation (3)
- Macrophages (3)
- Mortality (3)
- Peri-implantitis (3)
- Postural control (3)
- Quality of life (3)
- Stroke (3)
- TAVI (3)
- Treatment (3)
- inflammation (3)
- macrophage (3)
- miRNA (3)
- Ataxia telangiectasia (2)
- Bibliometrics (2)
- Clinical decision support systems (2)
- Computer-assisted diagnosis (2)
- EEG (2)
- Endoscopy (2)
- Epidemiology (2)
- Epilepsy (2)
- Genetics (2)
- Glioma (2)
- Healthy adults (2)
- Long-term potentiation (2)
- Outcome (2)
- Pneumonia (2)
- Rare diseases (2)
- Seizure (2)
- Wearable cardioverter-defibrillator (2)
- Women (2)
- bibliometrics (2)
- cancer (2)
- cerebral hemorrhage (2)
- cerebral venous thrombosis (2)
- coagulopathy (2)
- drug resistance (2)
- mTOR (2)
- obesity (2)
- patient blood management (2)
- polytrauma (2)
- post-translational modifications (2)
- psoriasis (2)
- public health (2)
- quality of life (2)
- sphingosine 1-phosphate (2)
- spinal dural leaks (2)
- stroke (2)
- sulforaphane (2)
- superficial siderosis (2)
- thymus (2)
- 3D printing (1)
- 3D rapid prototyping (1)
- 4-fluoroamphetamine (1)
- AAA+ disaggregase (1)
- ADAMTS13 (1)
- ADGRE1 (1)
- ADHD (1)
- AML (1)
- ARDS (1)
- ASPECTS (1)
- Abductor pollicis longus (1)
- Ablation (1)
- Abrasion (1)
- Abusive head trauma (AHT) (1)
- Accumulated degree days (1)
- Acute appendicitis (1)
- Acute elbow dislocation (1)
- Acute lymphoblastic leukemia (1)
- Acute-on-chronic subdural hematoma (1)
- Adherence (1)
- Administrative claims data (1)
- Adverse drug reaction (1)
- Age determination (1)
- Albumin ratio (1)
- Allogeneic (1)
- Amisulpride (1)
- Amitriptyline (1)
- Anal cancer (1)
- Anandamide (1)
- Anatomy (1)
- Anderson–Fabry (1)
- Angiogenesis (1)
- Animal model (1)
- Anti-inflammatory (1)
- Anti-rheumatic agents (1)
- Anticholinergic (1)
- Anticoagulant (1)
- Anticoagulation (1)
- Aortic input function (1)
- Appendectomy (1)
- Arrhythmia syndromes (1)
- Arthroplasty (1)
- Artificial intelligence (1)
- Ataxia score (1)
- Atm (1)
- Atrial fibrillation (1)
- Attention deficit (1)
- Autism spectrum disorder (1)
- Autoimmune vasculopathy (1)
- Autologous biomaterial (1)
- Axiography (1)
- BEZ235 (1)
- BMC (1)
- BMI (1)
- Bacterial abundance (1)
- Balloon-expandable TAVI (1)
- Benign enlargement of the subarachnoid spaces (BESS) (1)
- Bioenergetics (1)
- Biopsy (1)
- Bladder cancer (1)
- Bleeding (1)
- Blocked occlusion (1)
- Body modification (1)
- Bone defect (1)
- Bone regeneration (1)
- Bone remodelling (1)
- Bone substitute (1)
- Bone tissue engineering (1)
- Brain asymmetry (1)
- Brain injuries (1)
- Brain tumor surgery (1)
- Breast cancer survivers (1)
- Burden of illness (1)
- CAD/CAM (1)
- CCL2 (1)
- CD34 + cells (1)
- CD44 (1)
- CDI (1)
- CEBPD (1)
- COMP (1)
- COVID 19 pandemic (1)
- Calpain (1)
- Cancer (1)
- Capnography (1)
- Cardiac arrest (1)
- Cardiology (1)
- Cardiovascular magnetic resonance (1)
- Caspase-8 (1)
- Cell death and immune response (1)
- Cerebral hypoperfusion (1)
- Cerebrospinal fluid (1)
- Cerebrovascular disorders (1)
- Cezanne (1)
- Chemoradiotherapy (1)
- Child (1)
- Child abuse (1)
- Chronic inflammation (1)
- Classification (1)
- Clavien–Dindo classification (1)
- Climate inequity (1)
- Clinical genetics (1)
- Clinical trial (1)
- Coagulation (1)
- Cognition (1)
- Cold hardiness (1)
- Cold tolerance (1)
- Collagen-based biomaterial (1)
- Colonic neoplasms (1)
- Complications (1)
- Compression stocking (1)
- Computational biophysics (1)
- Confinement (1)
- Congenital diaphragmatic hernia (1)
- Connectivity (1)
- Conservative treatment (1)
- Constitution (1)
- Control (1)
- Cooperation (1)
- Copy number (1)
- Coronary artery disease (1)
- Cortical degeneration (1)
- Cortical thickness (1)
- Craniomaxillofacial injuries (1)
- Critical care (1)
- Critical size (1)
- Cryoelectron microscopy (1)
- Cystic fibrosis (1)
- Cytokines (1)
- DBS (1)
- DNA methylation (1)
- DST (1)
- Data science (1)
- Decontamination (1)
- Deep vein thrombosis (1)
- Defibrillation (1)
- Density equalizing mapping (1)
- Density-equalizing mapping (1)
- Dental air (1)
- Dental casts (1)
- Dental implant (1)
- Dental implants (1)
- Dental practice (1)
- Dental students (1)
- Depression (1)
- Diagnosis (1)
- Diagnostic algorithm (1)
- Diagnostic error (1)
- Differential diagnosis (1)
- Disaster victim identification (1)
- Disintegration (1)
- Distribution limits (1)
- Dopamine (1)
- Double-blind placebo-controlled trial (1)
- Drug susceptibility testing (1)
- Dural onlays (1)
- Dysphagia (1)
- EGFR (1)
- EGFRvIII mutation (1)
- EMR1 (1)
- EMT (1)
- Edoxaban (1)
- Education (1)
- Ejection fraction (1)
- Elderly (1)
- Electrical stimulation (1)
- Emergency treatment (1)
- Endocrinology (1)
- Endometrial carcinoma (1)
- Endothelial cells (1)
- Endothelial protein C receptor (1)
- Energy metabolism (1)
- Enterobacteriaceae (1)
- Epidural abscess (1)
- Evaluation (1)
- Evidence-based dentistry (1)
- Evidence-based medicine (1)
- Exercise challenge (1)
- Exercise-induced asthma (1)
- Exhaled nitric oxide (1)
- F4/80 (1)
- FBK-R23 (1)
- FEV1 (1)
- FHIR (1)
- FIH1 (1)
- FTMT (1)
- Fasting (1)
- Feedback (1)
- Female subjects (1)
- Ferritinophagy (1)
- Ferroptosis (1)
- Finevo (1)
- Fluid therapy (1)
- Forced expiratory volume in 1 s (1)
- Forensic entomology (1)
- Forensic examination (1)
- Fracture (1)
- Fracture type (1)
- Functional characterization (1)
- G-CSF (1)
- GLA deficiency (1)
- Gait analysis (1)
- Gastroschisis (1)
- Gene regulation (1)
- General practice (1)
- Genetic heart disease (1)
- Genetic syndromes (1)
- Geographical disparities (1)
- Global warming (1)
- Graph theory (1)
- Greenhouse effect (1)
- Guided bone regeneration (GBR) (1)
- Guided tissue regeneration (GTR) (1)
- HADS (1)
- HDAC and BET inhibitor (1)
- HDAC4 (1)
- HIV (1)
- HOSO (1)
- Haematocrit (1)
- Health care (1)
- Healthcare costs (1)
- Healthcare resource utilization (1)
- Heart failure (1)
- Heat shock protein 27 (1)
- Hemispheric specialization (1)
- Hemodynamics (1)
- Heterogeneity (1)
- High oblique sagittal osteotomy (1)
- Hippocampal excitability (1)
- Hippocampus (1)
- Histological analysis (1)
- HoLEP (1)
- Human behaviour (1)
- Hyperactivity (1)
- Hyperscanning (1)
- Hypoxia-inducible factor-1α (HIF-1α) (1)
- ICAM-1 (1)
- ICD (1)
- IDH mutation (1)
- IL-1β (1)
- ISR (1)
- Identification (1)
- Identifikation (1)
- Identifizierung von Katastrophenopfern (1)
- Immunohistochemistry (1)
- Immunology (1)
- Immunomodulatory agents (1)
- Implant osseointegration (1)
- Imrt (1)
- In vitro (1)
- In vivo (1)
- Inducible nitric oxide synthase (iNOS) (1)
- Induction chemotherapy (1)
- Infections (1)
- Inflammatory pattern (1)
- Injury Severity Score (ISS) (1)
- Innate immunity (1)
- Integrated Pulmonary Index (1)
- Integration (1)
- IntelliCage (1)
- Interoperability (1)
- Interposition (1)
- Interstitial pneumonia (1)
- Interview (1)
- Intravenous antibiotic therapy (1)
- Iron (1)
- Isocitrate dehydrogenase (1)
- JNK (1)
- Joint actions (1)
- Joint loading (1)
- K-homology RNA-binding domain (1)
- Kidney diseases (1)
- Körpermodifizierung (1)
- L-DOPA (1)
- Language delay (1)
- Lennox-Gastaut syndrome (1)
- Lockdown (1)
- Longchain polyunsaturated fatty acids (1)
- Low-dose radiation therapy (1)
- Lung cancer (1)
- Lung development (1)
- Lung function (1)
- Lung ultrasound (1)
- Lysophosphatidic acids (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- MRI (1)
- MS (1)
- Machine learning (1)
- Machine-learning (1)
- Macrophage polarization (1)
- Magnetic resonance imaging (1)
- Management (1)
- Mass disaster (1)
- Massenkatastrophe (1)
- Maxillofacial surgery (1)
- Mean erythrocyte volume (1)
- Medical research (1)
- Meta-analysis (1)
- Metabolic diseases (1)
- Michael acceptor (1)
- Microparticles (1)
- Mitochondrial dysfunction (1)
- Mobilization (1)
- Molecular autopsy (1)
- Molecular neuroscience (1)
- Monetary incentive delay (1)
- Mongolian spot (1)
- Monitoring (1)
- Monocytes (1)
- Morbidity (1)
- Morphologie (1)
- Morphology (1)
- Multidrug-resistance (1)
- Multimedication (1)
- Multimorbidity (1)
- Multiparametric MRI (1)
- Multiplate (1)
- Multiple-indication review (1)
- Myocardial infarction (MI) (1)
- Myocardial injury (1)
- Myocardial perfusion (1)
- NAFLD (1)
- NCOA4 (1)
- NCoR1 (1)
- NF-κB pathway (1)
- NIRS (1)
- NLRP3 inflammasomes (1)
- NTM (1)
- Negative appendectomy rate (1)
- Nek1 (1)
- Neonatal surgery outcome (1)
- Neurodegeneration (1)
- Neuron (1)
- Neurosurgery (1)
- Neurotransmitter (1)
- Nevus of Ito (1)
- Nevus of Ota (1)
- Next-generation sequencing (1)
- Non-abusive head trauma (NAHT) (1)
- Non-apoptotic functions (1)
- Non-tuberculous mycobacteria (1)
- Non-vitamin K antagonist oral anticoagulants (1)
- Normative modeling (1)
- Number of platelets (1)
- OSA (1)
- OTU domain-containing protein 7B (OTUD7B) (1)
- Omphalocele (1)
- Oncology (1)
- Oral anticoagulation (1)
- Orthognathic surgery (1)
- Osteoarthritis (1)
- Outcomes (1)
- Ovarian cancer treatment (1)
- Overwintering (1)
- PI3K/mTor inhibition (1)
- PV loop (1)
- PWI (1)
- Paediatric trauma patients (1)
- Pain (1)
- Parasympathetic (1)
- Patient blood management (1)
- Patient outcome assessment (1)
- Patient safety (1)
- Patterns of care (1)
- Pelvic (1)
- Percutaneous endoscopic gastrostomy (1)
- Periodontitis grades B and C (1)
- Periprocedural anticoagulation (1)
- Perrault syndrome (1)
- Phalangeal fractures (1)
- Phase I clinical trial (1)
- Phenotypic plasticity (1)
- Physical activity (1)
- Platelet-rich fibrin (1)
- Polygenic risk score (1)
- Polypharmacy (1)
- Post mortem interval (1)
- Pressure distribution (1)
- Pressure measuring plate (1)
- Prevalence (1)
- Prevention (1)
- Primary health care (1)
- Procedural skills (1)
- Prostate cancer (1)
- Pseudoprogression (1)
- Psychology (1)
- Pteridine (1)
- Pulmonary edema (1)
- Pulmonary embolism (1)
- Pulmonary hypertension (1)
- Pulmonary hypoplasia (1)
- Qualitative research (1)
- Quantitative (q)T2 mapping (1)
- Quantitative magnetic resonance imaging (1)
- Quantra (1)
- Questionnaire (1)
- Quinolones (1)
- RIPK1 (1)
- RNA chaperone (1)
- Radiomics (1)
- Ramadan (1)
- Refractory ALL (1)
- Refractory AML (1)
- RegJoint™ (1)
- Regeneration (1)
- Registries (1)
- Regret (1)
- Reliability (1)
- Rescue medication (1)
- Research investment (1)
- Respiratory distress syndrome (1)
- Retinal diseases (1)
- Retinoic acid (1)
- Return to work (1)
- Reward (1)
- Rheumatoid arthritis (1)
- Risk-stratification (1)
- S1P receptors (1)
- SCA2 (1)
- SCN5A (1)
- SEAP (1)
- SIDS (1)
- SLUG (1)
- SNORD95 (1)
- Safety (1)
- Saudi Arabia (1)
- Second donation (1)
- Self-expandable TAVI (1)
- Serious injured children (1)
- Serum biomarker (1)
- Sex (1)
- Sharp injuries (1)
- Shoulder luxation (1)
- Side effects (1)
- Signal intensity (1)
- Signs and symptoms (1)
- Social brain (1)
- Social differences (1)
- Socio-economic analysis (1)
- Socioeconomic analysis (1)
- Socioeconomic indices (1)
- Spine fractures (1)
- Spinocerebellar ataxia type 2 (1)
- Stage at presentation (1)
- Standard dataset (1)
- Standard reference values (1)
- Standard value (1)
- Status epilepticus (1)
- Stem cell (1)
- Sterols (1)
- Striatum (1)
- Stroke genetics (1)
- Sub-zero exposure (1)
- Sudden death (1)
- Sudden infant death syndrome (1)
- Surgery (1)
- Surgical therapy (1)
- Survey (1)
- Suspension (1)
- Swallowing (1)
- Sympathetic (1)
- Synaptic transmission (1)
- T cell receptor (1)
- T cells (1)
- T-cell receptor (1)
- T2 (1)
- TAMs (1)
- TGF-β (1)
- TGR(mREN2)27 (1)
- TRIMs (1)
- Targeted sequencing (1)
- Test assay (1)
- Therapies (1)
- Thrombotic thrombocytopenic purpura (1)
- Thumb carpometacarpal joint osteoarthritis (1)
- Tissue engineering (1)
- Tocilizumab (1)
- Total hip arthroplasty (1)
- Touchscreen (1)
- Transcription regulation (1)
- Transcriptional regulatory elements (1)
- Transfusion (1)
- Transfusion practice (1)
- Transgenic mice (1)
- Translation proteomics (1)
- TraumaRegister DGU® (TR-DGU) (1)
- Treatment effectiveness (1)
- Treatment rates (1)
- Treg cell (1)
- Tumor microenvironment (1)
- Type 2 diabetes (1)
- UBA domain (1)
- Ubiquitin ligase (1)
- Uncertainty (1)
- Undergraduate education (1)
- Upper body posture (1)
- VIM (1)
- Validation (1)
- Vascular endothelial growth factor (VEGF) (1)
- Venous thromboembolism (1)
- Ventricular arrhythmia (1)
- Ventricular arrhythmias (1)
- Videorasterstereography (1)
- Volume therapy (1)
- Volunteer donor (1)
- Watertight Dural closure (1)
- Western diet (1)
- Winter survival (1)
- Wound healing (1)
- Wounds (1)
- [18F]FET PET (1)
- activated clotting time measurement (1)
- adaptation (1)
- adhesion (1)
- adiabatic saturation (1)
- adipose-derived mesenchymal stem/stromal cells (1)
- adult (1)
- aging (1)
- alcoholic hepatitis (1)
- algorithm (1)
- allogeneic donor (1)
- allogeneic hematopoietic stem cell transplantation (1)
- alpha power (1)
- alpha-galactosidase A deficiency (1)
- alternative matrices (1)
- amyotrophic lateral sclerosis (ALS) (1)
- anaemia walk-in clinic (1)
- angiokeratoma diffuse (1)
- anti-inflammatory drug (1)
- aortic stenosis (1)
- apoptosis (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- aspiration (1)
- auditory fMRI (1)
- bacteria (1)
- bio imaging (1)
- bioactive lipids (1)
- bioavailability (1)
- bioluminescence (1)
- bipolar disorder (1)
- blinatumomab (1)
- blood pressure (1)
- blood transfusion (1)
- brain (1)
- brain shift (1)
- brain tumor (1)
- breast cancer (1)
- bypass (1)
- caesarean scar (1)
- caesarean section (1)
- cancer information (1)
- cancer specific survival (1)
- cardiothoracic surgery (1)
- cell death (1)
- ceramides (1)
- cerumen (1)
- cervical cancer (1)
- chemoprotection (1)
- chemoresistance (1)
- chemotaxis (1)
- chemotherapy (1)
- clinical immunology (1)
- coagulation (1)
- cognitive aging (1)
- colorectal cancer (1)
- colorectal cancer (CRC) (1)
- contamination (1)
- cortex (1)
- covalent drugs (1)
- curcumin (1)
- cyclin Y (1)
- cyclooxygenase 2 (1)
- cytokine storm (1)
- cytotoxic lymphocytes (1)
- cytotoxicity (1)
- data science (1)
- debris (1)
- deferred treatment (1)
- delayed treatment (1)
- delirium (1)
- demineralized bone matrix (1)
- dentoalveolar surgery (1)
- deubiquitinase (DUB) (1)
- deubiquitylation (deubiquitination) (1)
- donor safety (1)
- drug abstinence (1)
- dysphagia (1)
- early detection (1)
- electronic adherence measurement (1)
- electrophilic fatty acids (1)
- epidemics (1)
- epidemiology (1)
- epilepsy (1)
- episodic memory (1)
- epithelial-to-mesenchymal transition (EMT) (1)
- essential tremor (1)
- euthymic (1)
- everolimus (1)
- evolution (1)
- exercise (1)
- experimental pain models (1)
- fMRI (1)
- flow cytometry (1)
- focal cortical dysplasia (1)
- fractionation (1)
- fragile-X-associated tremor-ataxia syndrome (1)
- fronto-temporal lobar dementia (1)
- fronto-temporal-lobar-dementia (1)
- functional connectivity (1)
- gene regulation (1)
- geriatric patients (1)
- glioblastoma (1)
- glioblastoma cells (1)
- glioma (1)
- graph theory (1)
- growth (1)
- hemorrhage (1)
- hepatic stellate cells (1)
- hepatitis C virus (HCV) (1)
- hepatocellular cancer (1)
- hereditary dystopic lipidosis (1)
- high-throughput screening (1)
- hippocampus (1)
- histological outcomes (1)
- human genomics (1)
- hybrid abutment (1)
- hydroxylation (1)
- hypoxia (1)
- imaging (1)
- immune checkpoint (1)
- immune defense (1)
- immune response (1)
- immunity (1)
- immuno-oncotherapy (1)
- immunosuppression (1)
- immunotherapy (1)
- in vitro models (1)
- infection (1)
- inferior frontal gyrus (1)
- innate immunity (1)
- inositol signaling (1)
- integrated stress response (1)
- integrin (1)
- integrins (1)
- inter-individual variability (1)
- interferon type III (1)
- investigational (1)
- inflammation (1)
- iron deficiency (1)
- joint contact forces (1)
- knee adduction moment (1)
- lichen extracts (1)
- lipoxin A4 (1)
- liquid chromatography–mass spectrometry (1)
- liver fibrosis (1)
- long-term potentiation (1)
- long-term success (1)
- lymphocytes (1)
- machine learning (1)
- medication adherence rate (1)
- mental distress (1)
- mesenchymal stromal cells (1)
- mesenchymal stromal/stem cells (1)
- metabolism (1)
- miR-142-3p (1)
- miR-181 (1)
- miR-6862-5p (1)
- microRNA (1)
- mid-IR spectroscopy (1)
- migration (1)
- minimal residual disease (1)
- mitochondria (1)
- mitochondrial antiviral signaling protein (MAVS) (1)
- mitochondrial metabolism (1)
- mitochondrial morphology (1)
- mixed lineage kinase domain-like (1)
- molecular adaptation (1)
- molecular biology (1)
- molecular dynamics (1)
- monotype abutment (1)
- monsoon (1)
- mortality analysis (1)
- mortality risk (1)
- musculoskeletal inflammation (1)
- musculoskeletal modeling (1)
- neural oscillations (1)
- neurexin (1)
- next-generation sequencing (1)
- nitroalkylation (1)
- noninvasive blood glucose analysis (1)
- nuclear magnetic resonance (NMR) (1)
- nutrient endocytosis (1)
- oncogenic signaling (1)
- oral and maxillofacial surgery (1)
- orthopaedic patients (1)
- osteoarthritis (1)
- outside-in signaling (1)
- pain (1)
- patient’s decree (1)
- perceptual closure (1)
- pericytes (1)
- periodontal risk factors (1)
- photothermal detection (1)
- placenta (1)
- planimetric measurement (1)
- plasma (1)
- pneumocystis (1)
- point of care (1)
- poly(A)-tail (1)
- portal hypertension (1)
- post-caesarean uterus (1)
- post-exercise hypotension (1)
- posterior fossa tumor (1)
- postmonsoon (1)
- posttranslational modification (PTM) (1)
- precision weighting (1)
- predictive coding (1)
- prevalence (1)
- prognosis (1)
- prognostic marker (1)
- proliferation (1)
- prostate cancer (1)
- protease inhibitor (1)
- protein-protein interaction (1)
- proteostasis (1)
- psoriatic arthritis (1)
- qRT-PCR (1)
- quantum cascade laser (QCL) (1)
- radical prostatectomy (1)
- radiosensitization (1)
- rat femur critical size defect (1)
- regulatory T cell (1)
- regulatory T helper cells (1)
- relaxometry (1)
- renal cell carcinoma (1)
- renal transplantation (1)
- replicative fitness (1)
- resistance mutation (1)
- resolution of inflammation (1)
- reticulocyte haemoglobin (1)
- risk factor (1)
- risk factors (1)
- rotational thromboelastometry (1)
- scanner noise (1)
- schizophrenia (1)
- screening (1)
- selection (1)
- serine protease (NS3-4A) (1)
- serum (1)
- severely injured (1)
- signaling (1)
- simulation training (1)
- sonography (1)
- sparse imaging (1)
- spatial learning (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- sphingosine 1-phosphate receptor (1)
- sphingosine kinase (1)
- sphingosine-1-phosphate (1)
- spreading (1)
- starvation (1)
- steady-state condition (1)
- steatosis (1)
- stem cell transplantation (1)
- stem cells (1)
- stress (1)
- structure constraints (1)
- supportive periodontal therapy (1)
- survival (1)
- swallowing (1)
- synaesthesia (1)
- synaptic plasticity (1)
- tauopathies (1)
- tauopathy (1)
- thrombosis (1)
- tooth loss (1)
- total hip replacement (1)
- tracking (1)
- transcriptome (1)
- transferrin (1)
- translatome (1)
- transplantation (1)
- trauma registry (1)
- traumaticbraininjury(TBI) (1)
- tumor microenvironment (1)
- tyrosine kinase inhibitor (1)
- tyrosine kinase receptor signaling (1)
- ubiquitin (1)
- ubiquitin hydrolase (1)
- ultrasonic cleaning (1)
- unconventional T cell (1)
- uterine wall (1)
- variable silent delay (1)
- ventralis intermedius nucleus (1)
- vertical transmission (1)
- viruses (1)
- vitamin k antagonists (1)
- waiting time (1)
- walking (1)
- white matter hyperintensity (1)
- xenograft (1)
- fibrogenesis (1)
- fingolimod (1)
Institute
- Medizin (245)
- Biowissenschaften (3)
- Ernst Strüngmann Institut (3)
- Frankfurt Institute for Advanced Studies (FIAS) (3)
- MPI für Hirnforschung (3)
- Psychologie (2)
- Biochemie und Chemie (1)
- Biochemie, Chemie und Pharmazie (1)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (1)
- Informatik und Mathematik (1)
No disease modifying therapy is currently available for Parkinson’s disease (PD), the second most common neurodegenerative disease. The long non-motor prodromal phase of PD is a window of opportunity for early detection and intervention. However, we lack the pathophysiological understanding to develop selective biomarkers and interventions. By developing a mutant α-synuclein selective-overexpression mouse model of prodromal PD, we identified a cell-autonomous selective Kv4 channelopathy in dorsal motor nucleus of the vagus (DMV) neurons. This functional remodeling of intact DMV neurons leads to impaired pacemaker function in vitro and in vivo, which in turn reduces gastrointestinal motility which is a common, very early symptom of prodromal PD. We show for the first time a causal chain of events from α-synuclein via a biophysical dysfunction of specific neuronal populations to a clinically relevant prodromal symptom. These findings can facilitate the rational design of clinical biomarkers to identify people at risk for PD.
Objectives: The aim of the present study was to characterize the cellular reaction to a xenogeneic resorbable collagen membrane of porcine origin using a subcutaneous implantation model in Wistar rats over 30 days.
Materials and methods: Ex vivo, liquid platelet-rich fibrin (PRF), a leukocyte and platelet-rich cell suspension, was used to evaluate the blood cell membrane interaction. The material was implanted subcutaneously in rats. Sham-operated rats without biomaterial displayed physiological wound healing (control group). Histological, immunohistological, and histomorphometric analyses were focused on the inflammatory pattern, vascularization rate, and degradation pattern.
Results: The membrane induced a large number of mononuclear cells over the observation period, including lymphocytes, macrophages, and fibroblasts. After 15 days, multinucleated giant cells (MNGCs) were observed on the biomaterial surface. Their number increased significantly, and they proceeded to the center of the biomaterial on day 30. These cells highly expressed CD-68, calcitonin receptor, and MMP-9, but not TRAP or integrin-ß3. Thus, the membrane lost its integrity and underwent disintegration as a consequence of the induction of MNGCs. The significant increase in MNGC number correlated with a high rate of vascularization, which was significantly higher than the control group. Physiological wound healing in the control group did not induce any MNGCs at any time point. Ex vivo blood cells from liquid-PRF did not penetrate the membrane.
Conclusion: The present study suggests a potential role for MNGCs in biomaterial degradation and questions whether it is beneficial to accept them in clinically approved biomaterials or focus on biomaterials that induce only mononuclear cells. Thus, further studies are necessary to identify the function of biomaterial-induced MNGCs.
Clinical relevance: Understanding the cellular reaction to biomaterials is essential to assess their suitability for specific clinical indications and outline the potential benefit of specific group of biomaterials in the respective clinical indications.
Summary We introduce fsbrain, an R package for the visualization of neuroimaging data. The package can be used to visualize vertex-wise and region-wise morphometry data, parcellations, labels and statistical results on brain surfaces in three dimensions (3D). Voxel data can be displayed in lightbox mode. The fsbrain package offers various customization options and produces publication quality plots which can be displayed interactively, saved as bitmap images, or integrated into R notebooks.
Availability and Implementation The software, source code and documentation are available under the MIT license at https://github.com/dfsp-spirit/fsbrain. Releases can be installed directly from the Comprehensive R Archive Network (CRAN).
Achieving functional neuronal dendrite structure through sequential stochastic growth and retraction
(2020)
Class I ventral posterior dendritic arborisation (c1vpda) proprioceptive sensory neurons respond to contractions in the Drosophila larval body wall during crawling. Their dendritic branches run along the direction of contraction, possibly a functional requirement to maximise membrane curvature during crawling contractions. Although the molecular machinery of dendritic patterning in c1vpda has been extensively studied, the process leading to the precise elaboration of their comb-like shapes remains elusive. Here, to link dendrite shape with its proprioceptive role, we performed long-term, non-invasive, in vivo time-lapse imaging of c1vpda embryonic and larval morphogenesis to reveal a sequence of differentiation stages. We combined computer models and dendritic branch dynamics tracking to propose that distinct sequential phases of stochastic growth and retraction achieve efficient dendritic trees both in terms of wire and function. Our study shows how dendrite growth balances structure–function requirements, shedding new light on general principles of self-organisation in functionally specialised dendrites.
Achieving functional neuronal dendrite structure through sequential stochastic growth and retraction
(2020)
Class I ventral posterior dendritic arborisation (c1vpda) proprioceptive sensory neurons respond to contractions in the Drosophila larval body wall during crawling. Their dendritic branches run along the direction of contraction, possibly a functional requirement to maximise membrane curvature during crawling contractions. Although the molecular machinery of dendritic patterning in c1vpda has been extensively studied, the process leading to the precise elaboration of their comb-like shapes remains elusive. Here, to link dendrite shape with its proprioceptive role, we performed long-term, non-invasive, in vivo time-lapse imaging of c1vpda embryonic and larval morphogenesis to reveal a sequence of differentiation stages. We combined computer models and dendritic branch dynamics tracking to propose that distinct sequential phases of targeted growth and stochastic retraction achieve efficient dendritic trees both in terms of wire and function. Our study shows how dendrite growth balances structure–function requirements, shedding new light on general principles of self-organisation in functionally specialised dendrites.
SARS-CoV-2 infections are rapidly spreading around the globe. The rapid development of therapies is of major importance. However, our lack of understanding of the molecular processes and host cell signaling events underlying SARS-CoV-2 infection hinder therapy development. We employed a SARS-CoV-2 infection system in permissible human cells to study signaling changes by phospho-proteomics. We identified viral protein phosphorylation and defined phosphorylation-driven host cell signaling changes upon infection. Growth factor receptor (GFR) signaling and downstream pathways were activated. Drug-protein network analyses revealed GFR signaling as key pathway targetable by approved drugs. Inhibition of GFR downstream signaling by five compounds prevented SARS-CoV-2 replication in cells, assessed by cytopathic effect, viral dsRNA production, and viral RNA release into the supernatant. This study describes host cell signaling events upon SARS-CoV-2 infection and reveals GFR signaling as central pathway essential for SARS-CoV-2 replication. It provides with novel strategies for COVID-19 treatment.
The survivin suppressant YM155 is a drug candidate for neuroblastoma. Here, we tested YM155 in 101 neuroblastoma cell lines (19 parental cell lines, 82 drug-adapted sublines). 77 cell lines displayed YM155 IC50s in the range of clinical YM155 concentrations. ABCB1 was an important determinant of YM155 resistance. The activity of the ABCB1 inhibitor zosuquidar ranged from being similar to that of the structurally different ABCB1 inhibitor verapamil to being 65-fold higher. ABCB1 sequence variations may be responsible for this, suggesting that the design of variant-specific ABCB1 inhibitors may be possible. Further, we showed that ABCC1 confers YM155 resistance. Previously, p53 depletion had resulted in decreased YM155 sensitivity. However, TP53-mutant cells were not generally less sensitive to YM155 than TP53 wild-type cells in this study. Finally, YM155 cross-resistance profiles differed between cells adapted to drugs as similar as cisplatin and carboplatin. In conclusion, the large cell line panel was necessary to reveal an unanticipated complexity of the YM155 response in neuroblastoma cell lines with acquired drug resistance. Novel findings include that ABCC1 mediates YM155 resistance and that YM155 cross-resistance profiles differ between cell lines adapted to drugs as similar as cisplatin and carboplatin.
SARS-CoV-2 is a novel coronavirus currently causing a pandemic. We show that the majority of amino acid positions, which differ between SARS-CoV-2 and the closely related SARS-CoV, are differentially conserved suggesting differences in biological behaviour. In agreement, novel cell culture models revealed differences between the tropism of SARS-CoV-2 and SARS-CoV. Moreover, cellular ACE2 (SARS-CoV-2 receptor) and TMPRSS2 (enables virus entry via S protein cleavage) levels did not reliably indicate cell susceptibility to SARS-CoV-2. SARS-CoV-2 and SARS-CoV further differed in their drug sensitivity profiles. Thus, only drug testing using SARS-CoV-2 reliably identifies therapy candidates. Therapeutic concentrations of the approved protease inhibitor aprotinin displayed anti-SARS-CoV-2 activity. The efficacy of aprotinin and of remdesivir (currently under clinical investigation against SARS-CoV-2) were further enhanced by therapeutic concentrations of the proton pump inhibitor omeprazole (aprotinin 2.7-fold, remdesivir 10-fold). Hence, our study has also identified anti-SARS-CoV-2 therapy candidates that can be readily tested in patients.
SARS-CoV-2 is the causative agent of COVID-19. Severe COVID-19 disease has been associated with disseminated intravascular coagulation and thrombosis, but the mechanisms underlying COVID-19-related coagulopathy remain unknown. Since the risk of severe COVID-19 disease is higher in males than in females and increases with age, we combined proteomics data from SARS-CoV-2-infected cells with human gene expression data from the Genotype-Tissue Expression (GTEx) database to identify gene products involved in coagulation that change with age, differ in their levels between females and males, and are regulated in response to SARS-CoV-2 infection. This resulted in the identification of transferrin as a candidate coagulation promoter, whose levels increases with age and are higher in males than in females and that is increased upon SARS-CoV-2 infection. A systematic investigation of gene products associated with the GO term “blood coagulation” did not reveal further high confidence candidates, which are likely to contribute to COVID-19-related coagulopathy. In conclusion, the role of transferrin should be considered in the course of COVID-19 disease and further examined in ongoing clinic-pathological investigations.
The aim of this study is to provide a systematic assessment of the influence of the position on the arterial input function (AIF) for perfusion quantification. In 39 patients with a wide range of left ventricular function the AIF was determined using a diluted contrast bolus of a cardiac magnetic resonance imaging in three left ventricular levels (basal, mid, apex) as well as aortic sinus (AoS). Time to peak signal intensities, baseline corrected peak signal intensity and upslopes were determined and compared to those obtained in the AoS. The error induced by sampling the AIF in a position different to the AoS was determined by Fermi deconvolution. The time to peak signal intensity was strongly correlated (r2 > 0.9) for all positions with a systematic earlier arrival in the basal (− 2153 ± 818 ms), the mid (− 1429 ± 928 ms) and the apical slice (− 450 ± 739 ms) relative to the AoS (all p < 0.001). Peak signal intensity as well as upslopes were strongly correlated (r2 > 0.9 for both) for all positions with a systematic overestimation in all positions relative to the AoS (all p < 0.001 and all p < 0.05). Differences between the positions were more pronounced for patients with reduced ejection fraction. The error of averaged MBF quantification was 8%, 13% and 27% for the base, mid and apex. The location of the AIF significantly influences core parameters for perfusion quantification with a systematic and ejection fraction dependent error. Full quantification should be based on obtaining the AIF as close as possible to the myocardium to minimize these errors.